Jesse Treu, Director, Ten Percent Owner at Tobira Therapeutics, holds 1.89M shares in Aldeyra Therapeutics (Ticker: ALDX), holds 1.23M shares in Veracyte (Ticker: VCYT), holds 32.09K shares in Tobira Therapeutics (Ticker: TBRA). Most recently, Jesse Treu Sold ― shares of Aldeyra Therapeutics on Mar 28, 2019 for an estimated value of 968.40K.
Jesse Treu latest transaction was an Informative Sell of $968.40K.
What was Jesse Treu's most profitable transaction?
Jesse Treu’s most profitable transaction was an Informative Sell of ALDX stock on March 28, 2019. The return on the trade was 72.60%.
What is Jesse Treu's role in Tobira Therapeutics?
Jesse Treu's role in Tobira Therapeutics is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.